Skip to main content
. 2022 Apr 23;12(5):629. doi: 10.3390/life12050629

Table 1.

Characteristics of subjects in control and study groups.

Characteristics Control
(n = 50)
Group I
(n = 25)
Group II
(n = 25)
p-Value
Age (years) 50.7 ± 6.1 50.8 ± 4.3 53.1 ± 4.7 0.177
Duration of diabetes (years) 6.2 ± 2.5 8.4 ± 2.3 0.002
HbA1c (%) 5.4 ± 0.3 8.4 ± 1.2 9.9 ± 1.6 0.001
PSV of ophthalmic artery (cm/s) 31.9 ± 2.6 32.7 ± 3.0 33.8 ± 3.8 0.550
EDV of ophthalmic artery (cm/s) 8.7 ± 0.9 8.8 ± 1.6 8.3 ± 1.3 0.240
RI of ophthalmic artery 0.72 ± 0.02 0.73 ± 0.03 0.75 ± 0.03 <0.001
PSV of central retinal artery (cm/s) 16.1 ± 1.9 15.8 ± 3.1 14.2 ± 2.7 0.010
EDV of central retinal artery (cm/s) 5.1 ± 0.7 4.8 ± 1.1 3.9 ± 1.0 <0.001
RI of central retinal artery 0.68 ± 0.03 0.69 ± 0.03 0.72 ± 0.04 <0.001
PSV short posterior ciliary arteries (cm/s) 19.1 ± 2.5 18.0 ± 4.2 16.7 ± 4.9 0.030
EDV short posterior ciliary arteries (cm/s) 5.9 ± 0.7 5.1 ± 1.3 4.3 ± 1.0 <0.001
RI short posterior ciliary arteries 0.69 ± 0.03 0.71 ± 0.03 0.73 ± 0.5 <0.001

Group I—diabetic patients without retinopathy; Group II—diabetic patients with retinopathy. PSV—peak systolic velocity; EDV—end-diastolic velocity; RI—resistive index.